Keywords
Ingestible biosensors
Medication adherence
Digital health
Smart pharmaceuticals
Telemedicine
Categories
How to Cite
Abstract
Background: Medication non-adherence remains a critical global healthcare challenge, contributing to poor clinical outcomes, increased hospitalizations and rising healthcare costs. Conventional adherence assessment tools self-reports, pill counts, pharmacy refills are indirect and error-prone. Digital pills integrated with ingestible biosensors have emerged as a disruptive innovation offering objective, real-time confirmation of drug ingestion. Objective: This review critically examines the scientific principles, technological architectures, clinical applications, regulatory landscape and ethical considerations of digital pills and ingestible biosensors, with a focus on research trends from 2020-2025. Methods: A narrative and trend-based systematic review was conducted using PubMed, Scopus and Web of Science databases following PRISMA-informed principles. Peer-reviewed articles published between January 2020 and June 2025 were analyzed. Results: Ingestible biosensors demonstrate high accuracy in detecting medication ingestion and physiological parameters, particularly in psychiatry, cardiology, tuberculosis and transplant medicine. However, challenges persist related to cost, data privacy, patient autonomy, scalability and long-term clinical validation. Conclusion: Digital pills represent a paradigm shift in adherence science, transitioning from probabilistic estimates to direct biological confirmation. Future research must prioritize patient-centered design, ethical governance and integration with digital health ecosystems
References
[1] Gardezi SKM, Aitken WW, Jilani MH. The Impact of Non-Adherence to Antihypertensive Drug Therapy. Healthcare 2023;11:2979. https://doi.org/10.3390/healthcare11222979.
[2] Deng M, Zhai S, Ouyang X, Liu Z, Ross B. Factors influencing medication adherence among patients with severe mental disorders from the perspective of mental health professionals. BMC Psychiatry 2022;22:22. https://doi.org/10.1186/s12888-021-03681-6.
[3] Ingestible biosensors for monitoring digestive health and nutritional monitoring, 2025, p. 351–71. https://doi.org/10.1016/bs.pmbts.2025.06.007.
[4] Brasier N, Wang J, Gao W, Sempionatto JR, Dincer C, Ates HC, et al. Applied body-fluid analysis by wearable devices. Nature 2024;636:57–68. https://doi.org/10.1038/s41586-024-08249-4.
[5] Caicedo-Eraso JC, Castrillon-Arias CG, Varon-Serna DR. Virtual reality in health sciences. Health Technol (Berl) 2026. https://doi.org/10.1007/s12553-025-01034-x.
[6] Morrison EA, Adu DA, Guo Y. Executive compensation, sustainable business practices and firm performance: a systematic literature review and future research agenda. Journal of Accounting Literature 2026;48:224–48. https://doi.org/10.1108/JAL-03-2023-0040.
[7] Sharma A, Fuloria NK, Singh PK, Sharma S, editors. The Digital Pillbox: Integrating AI, IoT, and Pharma Solutions (Part 2). BENTHAM SCIENCE PUBLISHERS; 2025. https://doi.org/10.2174/97988988106961250101.
[8] Divya R, Sadana Shree S, Sakthiganesh V, Gokulkumar K, Monisha A. Digital Pills: Enhancing patient outcomes through innovative medication management. Comput Biol Med 2025;196:110907. https://doi.org/10.1016/j.compbiomed.2025.110907.
[9] Singh S, Rai S, Bandopadhyay A, Das M. From detection to drug delivery: innovations in cancer biosensors from concept to clinical impact. Biotechnology for Sustainable Materials 2025;2:17. https://doi.org/10.1186/s44316-025-00040-3.
[10] Mitrakas C, Xanthopoulos A, Koulouriotis D. Techniques and Models for Addressing Occupational Risk Using Fuzzy Logic, Neural Networks, Machine Learning, and Genetic Algorithms: A Review and Meta-Analysis. Applied Sciences 2025;15:1909. https://doi.org/10.3390/app15041909.
[11] Baumgartner S, Ceppi E, Longrée P, Salvisberg M, Singer H, Ort C. Intraday trends of chemical biomarkers in wastewater monitored through automated real-time surveillance. Water Res 2025;287:124337. https://doi.org/10.1016/j.watres.2025.124337.
[12] Santos CS, Amorim-Lopes M. Externally validated and clinically useful machine learning algorithms to support patient-related decision-making in oncology: a scoping review. BMC Med Res Methodol 2025;25:45. https://doi.org/10.1186/s12874-025-02463-y.
[13] Hausner E, Sturtz S, Molnar S, Schell L, Sieben W, Sauerland S. Searching for non-English literature may be unnecessary for German HTA Reports. F1000Res 2025;13:1134. https://doi.org/10.12688/f1000research.151365.3.
[14] Fertig MR, Lee JS, Rabie S, Tshukuse Y, Ncukana M, Ashar DA, et al. Attitudes toward digital pill systems for antiretroviral therapy adherence among pregnant and postpartum women living with HIV in South Africa: a qualitative study. Front Psychiatry 2025;16. https://doi.org/10.3389/fpsyt.2025.1667547.
[15] Girard AA, Sperry BW. Contextualizing the results of HELIOS-B in the broader landscape of clinical trials for the treatment of transthyretin cardiac amyloidosis. Heart Fail Rev 2024;30:69–73. https://doi.org/10.1007/s10741-024-10444-4.
[16] Bero L, Banacos N, Baugh CM, Chai PR, Glynn TR, DeCamp M, et al. Ethical, legal, and social issues related to ingestible, implantable electronic devices and mRNA delivery devices. Device 2025;3:100841. https://doi.org/10.1016/j.device.2025.100841.
[17] Nadeem-Tariq A, Fang CJ, Hii JL, Nelson K. Biosensor-Integrated Tibial Components in Total Knee Arthroplasty: A Narrative Review of Innovations, Challenges, and Translational Frontiers. Bioengineering 2025;12:988. https://doi.org/10.3390/bioengineering12090988.
[18] Dutta S, Havanagi S, Mishra P, Sharma D, Singh BN. From inert to intelligent: smart biomaterials reshaping the landscape of bioengineering. Int J Smart Nano Mater 2025;16:845–77. https://doi.org/10.1080/19475411.2025.2570535.
[19] Boopathi Raja G. Advancements of IoT and sensor informatics in wearable, implantable, mobile, and remote healthcare. Innovations in Biomedical Engineering, Elsevier; 2025, p. 87–121. https://doi.org/10.1016/B978-0-443-30146-9.00003-4.
[20] Litvinova O, Klager E, Tzvetkov NT, Kimberger O, Kletecka-Pulker M, Willschke H, et al. Digital Pills with Ingestible Sensors: Patent Landscape Analysis. Pharmaceuticals 2022;15:1025. https://doi.org/10.3390/ph15081025.
[21] Ramdani S, Benkaddour NEH, Haddiya I. Digital advancements in hypertension management. 2024 3rd International Conference on Embedded Systems and Artificial Intelligence (ESAI), IEEE; 2024, p. 1–13. https://doi.org/10.1109/ESAI62891.2024.10913561.
[22] Loupy A, Sablik M, Khush K, Reese PP. Advancing patient monitoring, diagnostics, and treatment strategies for transplant precision medicine. The Lancet 2025;406:389–402. https://doi.org/10.1016/S0140-6736(25)00195-3.
[23] Chen K, Lim TP, Yuen JSP, Ho H, Murphy DG. Regulatory considerations for new drugs and devices. Translational Urology, Elsevier; 2025, p. 293–9. https://doi.org/10.1016/B978-0-323-90186-4.00060-2.
[24] Paci MM, Saha T, Djassemi O, Wu S, Chua CYX, Wang J, et al. Smart closed-loop drug delivery systems. Nature Reviews Bioengineering 2025;3:816–34. https://doi.org/10.1038/s44222-025-00328-z.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2026 Journal of Public Health and Preventive Medicine